(5) Dimet-Wiley AL, Latham CM, Brightwell CR, Neelakantan H, Keeble AR, Thomas NT, Noehren H, Fry CS, Watowich SJ
In a double-blind study with a placebo group, chronic insomniac patients administered with a DSIP analogue experienced a reduction in sleep latency by an average of 22 minutes, suggesting its potential as a therapeutic agent for severe chronic insomnia patients (Anderer & Saletu, 1991)
At Orthobiologics Associates, we offer treatments like PRP therapy, functional rehabilitation, and epidural steroid injections
[PMID: 14718366] PubMed record related to this compound for laboratory literature review